BRISBANE, Australia--(BUSINESS WIRE)--The directors of Progen Pharmaceuticals Limited (“Progen”) (ASX:PGL) (NASDAQ:PGLA) today released the Notice of Meeting regarding the Avexa merger and share buy back and confirmed their unanimous recommendation for the proposed merger with Avexa Limited (“Avexa”) (ASX:AVX). The Progen shareholder meeting to consider the merger will be held on 11 March 2009.
